0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Procalcitonin Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-19M9390
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Procalcitonin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Procalcitonin Market Research Report 2026

Code: QYRE-Auto-19M9390
Report
2026-02-10
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Procalcitonin Market Size

The global Procalcitonin market was valued at US$ 88.25 million in 2025 and is anticipated to reach US$ 144 million by 2032, at a CAGR of 7.3% from 2026 to 2032.

Procalcitonin Market

Procalcitonin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Procalcitonin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
This report delivers a comprehensive overview of the global Procalcitonin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Procalcitonin. The Procalcitonin market size, estimates, and forecasts are provided in terms of sales volume (mg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Procalcitonin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Procalcitonin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Procalcitonin Market Report

Report Metric Details
Report Name Procalcitonin Market
Accounted market size in 2025 US$ 88.25 million
Forecasted market size in 2032 US$ 144 million
CAGR 7.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Procalcitonin Antigen
  • Procalcitonin Antibody
by Application
  • Medical Industry
  • Scientific Research
  • Veterinarian
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Procalcitonin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Procalcitonin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Procalcitonin Market growing?

Ans: The Procalcitonin Market witnessing a CAGR of 7.3% during the forecast period 2026-2032.

What is the Procalcitonin Market size in 2032?

Ans: The Procalcitonin Market size in 2032 will be US$ 144 million.

What is the market share of major companies in Procalcitonin Market?

Ans: Global top five manufacturers hold a share about 35%.

What is the Procalcitonin Market share by type?

Ans: In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%.

Who are the main players in the Procalcitonin Market report?

Ans: The main players in the Procalcitonin Market are Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis

What are the Application segmentation covered in the Procalcitonin Market report?

Ans: The Applications covered in the Procalcitonin Market report are Medical Industry, Scientific Research, Veterinarian

What are the Type segmentation covered in the Procalcitonin Market report?

Ans: The Types covered in the Procalcitonin Market report are Procalcitonin Antigen, Procalcitonin Antibody

1 Procalcitonin Market Overview
1.1 Product Definition
1.2 Procalcitonin by Type
1.2.1 Global Procalcitonin Market Value by Type: 2025 vs 2032
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin by Application
1.3.1 Global Procalcitonin Market Value by Application: 2025 vs 2032
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Global Procalcitonin Market Size Estimates and Forecasts
1.4.1 Global Procalcitonin Revenue 2021–2032
1.4.2 Global Procalcitonin Sales 2021–2032
1.4.3 Global Procalcitonin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Procalcitonin Market Competition by Manufacturers
2.1 Global Procalcitonin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Procalcitonin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Procalcitonin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Procalcitonin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Procalcitonin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Procalcitonin, Product Types and Applications
2.7 Global Key Manufacturers of Procalcitonin, Date of Entry into the Industry
2.8 Global Procalcitonin Market Competitive Situation and Trends
2.8.1 Global Procalcitonin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Procalcitonin Players Market Share by Revenue
2.8.3 Global Procalcitonin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Procalcitonin Market Scenario by Region
3.1 Global Procalcitonin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Procalcitonin Sales by Region: 2021–2032
3.2.1 Global Procalcitonin Sales by Region: 2021–2026
3.2.2 Global Procalcitonin Sales by Region: 2027–2032
3.3 Global Procalcitonin Revenue by Region: 2021–2032
3.3.1 Global Procalcitonin Revenue by Region: 2021–2026
3.3.2 Global Procalcitonin Revenue by Region: 2027–2032
3.4 North America Procalcitonin Market Facts & Figures by Country
3.4.1 North America Procalcitonin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Procalcitonin Sales by Country (2021–2032)
3.4.3 North America Procalcitonin Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Procalcitonin Market Facts & Figures by Country
3.5.1 Europe Procalcitonin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Procalcitonin Sales by Country (2021–2032)
3.5.3 Europe Procalcitonin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Procalcitonin Market Facts & Figures by Region
3.6.1 Asia Pacific Procalcitonin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Procalcitonin Sales by Region (2021–2032)
3.6.3 Asia Pacific Procalcitonin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Procalcitonin Market Facts & Figures by Country
3.7.1 Latin America Procalcitonin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Procalcitonin Sales by Country (2021–2032)
3.7.3 Latin America Procalcitonin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Procalcitonin Market Facts & Figures by Country
3.8.1 Middle East and Africa Procalcitonin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Procalcitonin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Procalcitonin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Procalcitonin Sales by Type (2021–2032)
4.1.1 Global Procalcitonin Sales by Type (2021–2026)
4.1.2 Global Procalcitonin Sales by Type (2027–2032)
4.1.3 Global Procalcitonin Sales Market Share by Type (2021–2032)
4.2 Global Procalcitonin Revenue by Type (2021–2032)
4.2.1 Global Procalcitonin Revenue by Type (2021–2026)
4.2.2 Global Procalcitonin Revenue by Type (2027–2032)
4.2.3 Global Procalcitonin Revenue Market Share by Type (2021–2032)
4.3 Global Procalcitonin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Procalcitonin Sales by Application (2021–2032)
5.1.1 Global Procalcitonin Sales by Application (2021–2026)
5.1.2 Global Procalcitonin Sales by Application (2027–2032)
5.1.3 Global Procalcitonin Sales Market Share by Application (2021–2032)
5.2 Global Procalcitonin Revenue by Application (2021–2032)
5.2.1 Global Procalcitonin Revenue by Application (2021–2026)
5.2.2 Global Procalcitonin Revenue by Application (2027–2032)
5.2.3 Global Procalcitonin Revenue Market Share by Application (2021–2032)
5.3 Global Procalcitonin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Procalcitonin Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Company Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Roche Diagnostics Procalcitonin Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 bioMerieux
6.3.1 bioMerieux Company Information
6.3.2 bioMerieux Description and Business Overview
6.3.3 bioMerieux Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 bioMerieux Procalcitonin Product Portfolio
6.3.5 bioMerieux Recent Developments/Updates
6.4 HyTest
6.4.1 HyTest Company Information
6.4.2 HyTest Description and Business Overview
6.4.3 HyTest Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HyTest Procalcitonin Product Portfolio
6.4.5 HyTest Recent Developments/Updates
6.5 BBI Solutions
6.5.1 BBI Solutions Company Information
6.5.2 BBI Solutions Description and Business Overview
6.5.3 BBI Solutions Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BBI Solutions Procalcitonin Product Portfolio
6.5.5 BBI Solutions Recent Developments/Updates
6.6 ProSpec
6.6.1 ProSpec Company Information
6.6.2 ProSpec Description and Business Overview
6.6.3 ProSpec Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ProSpec Procalcitonin Product Portfolio
6.6.5 ProSpec Recent Developments/Updates
6.7 Wondfo
6.7.1 Wondfo Company Information
6.7.2 Wondfo Description and Business Overview
6.7.3 Wondfo Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Wondfo Procalcitonin Product Portfolio
6.7.5 Wondfo Recent Developments/Updates
6.8 Ningbo Medicalsystem Biotechnology
6.8.1 Ningbo Medicalsystem Biotechnology Company Information
6.8.2 Ningbo Medicalsystem Biotechnology Description and Business Overview
6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
6.9 Wuhan Easy Diagnosis Biomedicine
6.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
6.9.2 Wuhan Easy Diagnosis Biomedicine Description and Business Overview
6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
6.10 Snibe
6.10.1 Snibe Company Information
6.10.2 Snibe Description and Business Overview
6.10.3 Snibe Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Snibe Procalcitonin Product Portfolio
6.10.5 Snibe Recent Developments/Updates
6.11 Vazyme Biotech
6.11.1 Vazyme Biotech Company Information
6.11.2 Vazyme Biotech Description and Business Overview
6.11.3 Vazyme Biotech Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Vazyme Biotech Procalcitonin Product Portfolio
6.11.5 Vazyme Biotech Recent Developments/Updates
6.12 Getein Biotech
6.12.1 Getein Biotech Company Information
6.12.2 Getein Biotech Description and Business Overview
6.12.3 Getein Biotech Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Getein Biotech Procalcitonin Product Portfolio
6.12.5 Getein Biotech Recent Developments/Updates
6.13 Hotgen Biotech
6.13.1 Hotgen Biotech Company Information
6.13.2 Hotgen Biotech Description and Business Overview
6.13.3 Hotgen Biotech Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hotgen Biotech Procalcitonin Product Portfolio
6.13.5 Hotgen Biotech Recent Developments/Updates
6.14 Lumigenex
6.14.1 Lumigenex Company Information
6.14.2 Lumigenex Description and Business Overview
6.14.3 Lumigenex Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Lumigenex Procalcitonin Product Portfolio
6.14.5 Lumigenex Recent Developments/Updates
6.15 Nanjing Norman Biological Technology
6.15.1 Nanjing Norman Biological Technology Company Information
6.15.2 Nanjing Norman Biological Technology Description and Business Overview
6.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
6.15.5 Nanjing Norman Biological Technology Recent Developments/Updates
6.16 Kitgen
6.16.1 Kitgen Company Information
6.16.2 Kitgen Description and Business Overview
6.16.3 Kitgen Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Kitgen Procalcitonin Product Portfolio
6.16.5 Kitgen Recent Developments/Updates
6.17 Beijing KeyGen
6.17.1 Beijing KeyGen Company Information
6.17.2 Beijing KeyGen Description and Business Overview
6.17.3 Beijing KeyGen Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Beijing KeyGen Procalcitonin Product Portfolio
6.17.5 Beijing KeyGen Recent Developments/Updates
6.18 Beijing Apis
6.18.1 Beijing Apis Company Information
6.18.2 Beijing Apis Description and Business Overview
6.18.3 Beijing Apis Procalcitonin Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Beijing Apis Procalcitonin Product Portfolio
6.18.5 Beijing Apis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Procalcitonin Industry Chain Analysis
7.2 Procalcitonin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Procalcitonin Production Mode & Process Analysis
7.4 Procalcitonin Sales and Marketing
7.4.1 Procalcitonin Sales Channels
7.4.2 Procalcitonin Distributors
7.5 Procalcitonin Customer Analysis
8 Procalcitonin Market Dynamics
8.1 Procalcitonin Industry Trends
8.2 Procalcitonin Market Drivers
8.3 Procalcitonin Market Challenges
8.4 Procalcitonin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Procalcitonin Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Procalcitonin Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Procalcitonin Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Procalcitonin Sales (mg) of Key Manufacturers (2021–2026)
 Table 5. Global Procalcitonin Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Procalcitonin Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Procalcitonin Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Procalcitonin Average Price (USD/mg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Procalcitonin, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Procalcitonin, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Procalcitonin, Product Types and Applications
 Table 12. Global Key Manufacturers of Procalcitonin, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Procalcitonin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Procalcitonin Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Procalcitonin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Procalcitonin Sales by Region (mg), 2021–2026
 Table 18. Global Procalcitonin Sales Market Share by Region (2021–2026)
 Table 19. Global Procalcitonin Sales by Region (mg), 2027–2032
 Table 20. Global Procalcitonin Sales Market Share by Region (2027–2032)
 Table 21. Global Procalcitonin Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Procalcitonin Revenue Market Share by Region (2021–2026)
 Table 23. Global Procalcitonin Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Procalcitonin Revenue Market Share by Region (2027–2032)
 Table 25. North America Procalcitonin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Procalcitonin Sales by Country (mg), 2021–2026
 Table 27. North America Procalcitonin Sales by Country (mg), 2027–2032
 Table 28. North America Procalcitonin Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Procalcitonin Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Procalcitonin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Procalcitonin Sales by Country (mg), 2021–2026
 Table 32. Europe Procalcitonin Sales by Country (mg), 2027–2032
 Table 33. Europe Procalcitonin Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Procalcitonin Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Procalcitonin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Procalcitonin Sales by Region (mg), 2021–2026
 Table 37. Asia Pacific Procalcitonin Sales by Region (mg), 2027–2032
 Table 38. Asia Pacific Procalcitonin Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Procalcitonin Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Procalcitonin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Procalcitonin Sales by Country (mg), 2021–2026
 Table 42. Latin America Procalcitonin Sales by Country (mg), 2027–2032
 Table 43. Latin America Procalcitonin Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Procalcitonin Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Procalcitonin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Procalcitonin Sales by Country (mg), 2021–2026
 Table 47. Middle East and Africa Procalcitonin Sales by Country (mg), 2027–2032
 Table 48. Middle East and Africa Procalcitonin Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Procalcitonin Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Procalcitonin Sales (mg) by Type (2021–2026)
 Table 51. Global Procalcitonin Sales (mg) by Type (2027–2032)
 Table 52. Global Procalcitonin Sales Market Share by Type (2021–2026)
 Table 53. Global Procalcitonin Sales Market Share by Type (2027–2032)
 Table 54. Global Procalcitonin Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Procalcitonin Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Procalcitonin Revenue Market Share by Type (2021–2026)
 Table 57. Global Procalcitonin Revenue Market Share by Type (2027–2032)
 Table 58. Global Procalcitonin Price (USD/mg) by Type (2021–2026)
 Table 59. Global Procalcitonin Price (USD/mg) by Type (2027–2032)
 Table 60. Global Procalcitonin Sales (mg) by Application (2021–2026)
 Table 61. Global Procalcitonin Sales (mg) by Application (2027–2032)
 Table 62. Global Procalcitonin Sales Market Share by Application (2021–2026)
 Table 63. Global Procalcitonin Sales Market Share by Application (2027–2032)
 Table 64. Global Procalcitonin Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Procalcitonin Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Procalcitonin Revenue Market Share by Application (2021–2026)
 Table 67. Global Procalcitonin Revenue Market Share by Application (2027–2032)
 Table 68. Global Procalcitonin Price (USD/mg) by Application (2021–2026)
 Table 69. Global Procalcitonin Price (USD/mg) by Application (2027–2032)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Procalcitonin Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. Roche Diagnostics Company Information
 Table 76. Roche Diagnostics Description and Business Overview
 Table 77. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 78. Roche Diagnostics Procalcitonin Product
 Table 79. Roche Diagnostics Recent Developments/Updates
 Table 80. bioMerieux Company Information
 Table 81. bioMerieux Description and Business Overview
 Table 82. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 83. bioMerieux Procalcitonin Product
 Table 84. bioMerieux Recent Developments/Updates
 Table 85. HyTest Company Information
 Table 86. HyTest Description and Business Overview
 Table 87. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 88. HyTest Procalcitonin Product
 Table 89. HyTest Recent Developments/Updates
 Table 90. BBI Solutions Company Information
 Table 91. BBI Solutions Description and Business Overview
 Table 92. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 93. BBI Solutions Procalcitonin Product
 Table 94. BBI Solutions Recent Developments/Updates
 Table 95. ProSpec Company Information
 Table 96. ProSpec Description and Business Overview
 Table 97. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 98. ProSpec Procalcitonin Product
 Table 99. ProSpec Recent Developments/Updates
 Table 100. Wondfo Company Information
 Table 101. Wondfo Description and Business Overview
 Table 102. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 103. Wondfo Procalcitonin Product
 Table 104. Wondfo Recent Developments/Updates
 Table 105. Ningbo Medicalsystem Biotechnology Company Information
 Table 106. Ningbo Medicalsystem Biotechnology Description and Business Overview
 Table 107. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 108. Ningbo Medicalsystem Biotechnology Procalcitonin Product
 Table 109. Ningbo Medicalsystem Biotechnology Recent Developments/Updates
 Table 110. Wuhan Easy Diagnosis Biomedicine Company Information
 Table 111. Wuhan Easy Diagnosis Biomedicine Description and Business Overview
 Table 112. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 113. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product
 Table 114. Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
 Table 115. Snibe Company Information
 Table 116. Snibe Description and Business Overview
 Table 117. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 118. Snibe Procalcitonin Product
 Table 119. Snibe Recent Developments/Updates
 Table 120. Vazyme Biotech Company Information
 Table 121. Vazyme Biotech Description and Business Overview
 Table 122. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 123. Vazyme Biotech Procalcitonin Product
 Table 124. Vazyme Biotech Recent Developments/Updates
 Table 125. Getein Biotech Company Information
 Table 126. Getein Biotech Description and Business Overview
 Table 127. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 128. Getein Biotech Procalcitonin Product
 Table 129. Getein Biotech Recent Developments/Updates
 Table 130. Hotgen Biotech Company Information
 Table 131. Hotgen Biotech Description and Business Overview
 Table 132. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 133. Hotgen Biotech Procalcitonin Product
 Table 134. Hotgen Biotech Recent Developments/Updates
 Table 135. Lumigenex Company Information
 Table 136. Lumigenex Description and Business Overview
 Table 137. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 138. Lumigenex Procalcitonin Product
 Table 139. Lumigenex Recent Developments/Updates
 Table 140. Nanjing Norman Biological Technology Company Information
 Table 141. Nanjing Norman Biological Technology Description and Business Overview
 Table 142. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 143. Nanjing Norman Biological Technology Procalcitonin Product
 Table 144. Nanjing Norman Biological Technology Recent Developments/Updates
 Table 145. Kitgen Company Information
 Table 146. Kitgen Description and Business Overview
 Table 147. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 148. Kitgen Procalcitonin Product
 Table 149. Kitgen Recent Developments/Updates
 Table 150. Beijing KeyGen Company Information
 Table 151. Beijing KeyGen Description and Business Overview
 Table 152. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 153. Beijing KeyGen Procalcitonin Product
 Table 154. Beijing KeyGen Recent Developments/Updates
 Table 155. Beijing Apis Company Information
 Table 156. Beijing Apis Description and Business Overview
 Table 157. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg), and Gross Margin (2021–2026)
 Table 158. Beijing Apis Procalcitonin Product
 Table 159. Beijing Apis Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Procalcitonin Distributors List
 Table 163. Procalcitonin Customers List
 Table 164. Procalcitonin Market Trends
 Table 165. Procalcitonin Market Drivers
 Table 166. Procalcitonin Market Challenges
 Table 167. Procalcitonin Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Procalcitonin
 Figure 2. Global Procalcitonin Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Procalcitonin Market Share by Type: 2025 & 2032
 Figure 4. Procalcitonin Antigen Product Picture
 Figure 5. Procalcitonin Antibody Product Picture
 Figure 6. Global Procalcitonin Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Procalcitonin Market Share by Application: 2025 & 2032
 Figure 8. Medical Industry
 Figure 9. Scientific Research
 Figure 10. Veterinarian
 Figure 11. Global Procalcitonin Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Procalcitonin Market Size (US$ Million), 2021–2032
 Figure 13. Global Procalcitonin Sales (mg), 2021–2032
 Figure 14. Global Procalcitonin Average Price (USD/mg), 2021–2032
 Figure 15. Procalcitonin Report Years Considered
 Figure 16. Procalcitonin Sales Share by Manufacturers in 2025
 Figure 17. Global Procalcitonin Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Procalcitonin Players: Market Share by Revenue in Procalcitonin in 2025
 Figure 19. Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Procalcitonin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Procalcitonin Sales Market Share by Country (2021–2032)
 Figure 22. North America Procalcitonin Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Procalcitonin Sales Market Share by Country (2021–2032)
 Figure 26. Europe Procalcitonin Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Procalcitonin Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Procalcitonin Revenue Market Share by Region (2021–2032)
 Figure 34. China Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Procalcitonin Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Procalcitonin Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Procalcitonin Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Procalcitonin Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Procalcitonin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Procalcitonin by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Procalcitonin by Type (2021–2032)
 Figure 56. Global Procalcitonin Price (USD/mg) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Procalcitonin by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Procalcitonin by Application (2021–2032)
 Figure 59. Global Procalcitonin Price (USD/mg) by Application (2021–2032)
 Figure 60. Procalcitonin Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture